Peptides · Peptide comparison
Relaxin-2 (Serelaxin) vs TB-500
Recombinant human relaxin-2 studied for acute heart failure recovery and cardiovascular support
A powerful fragment of thymosin beta-4 that acts like your body's repair signal—speeding up healing of muscles, tendons, and tissues by promoting cell migration and new blood vessel growth right where you need it most.
- Healing & Recovery
- Healing & Recovery
At a glance
Quick comparison
Efficacy
Benefit ratings
Cardiovascular Function
Heart Failure Support
Acute Medical Management
Healing Speed
Tissue Repair
Anti-Scarring
Technical data
Compound specifications
Relaxin-2 (Serelaxin)
- Molecular formula
- C256H408N74O74S8
- Molecular weight
- 5,963 Da (Daltons)
- Half-life
- Varies by route of administration
- Bioavailability
- Varies by route of administration
- CAS number
- See PubChem for identifiers
TB-500
- Molecular formula
- C38H68N10O14
- Molecular weight
- 889.01 g/mol
- Half-life
- 2-3 days (systemic)
- Bioavailability
- High via subcutaneous injection (~100%)
- CAS number
- 885340-08-9
Protocols
Dosing compared
Relaxin-2 (Serelaxin)
Intravenous
- 30 mcg/kg/dayContinuous IV infusion · 48 hoursWeight-adjusted continuous IV infusion used across the RELAX-AHF programme for acute heart failure; improved dyspnea but did not reduce mortality in RELAX-AHF-2 [3][5]. Hospital administration only.
TB-500
Subcutaneous
- 2-2.5 mgTwice weekly · Loading phase, 4-6 weeksResearch peptide with no human trials of the fragment; [9] loading doses used in practice [6].
- 2-2.5 mgOnce weekly · Maintenance after loadingMaintenance dose used in practice following the loading phase [6].
Applications
Best suited for
Relaxin-2 (Serelaxin)
- Acute heart failure symptom management
- Relaxin-2 (Serelaxin) is particularly effective for individuals focused on acute heart failure symptom management. Research supports its use in this area [5][9].
- Cardiovascular recovery and support
- Relaxin-2 (Serelaxin) is particularly effective for individuals focused on cardiovascular recovery and support. Research supports its use in this area [2].
- Hospital-based therapeutic interventions
- Relaxin-2 (Serelaxin) is particularly effective for individuals focused on hospital-based therapeutic interventions. Research supports its use in this area [3][15].
TB-500
- Athletes Recovering from Muscle Injuries
- If you've pulled a hamstring, strained your back, or torn a muscle, TB-500 helps accelerate the healing process by promoting cell migration to the injury site and supporting new blood vessel growth. It's especially useful for injuries that just won't seem to fully heal [1][5].
- Tendon and Ligament Problems
- Tendons and ligaments are notoriously slow healers because they have poor blood supply. TB-500 promotes angiogenesis (new blood vessel formation) and helps repair these stubborn connective tissue injuries—think Achilles tendonitis, tennis elbow, or rotator cuff issues [5].
- Post-Surgical Recovery
- After surgery, your body needs to repair a lot of tissue quickly. TB-500 supports wound healing, reduces inflammation, and may help minimize scar tissue formation. Some protocols use it alongside traditional recovery to potentially speed up the healing timeline [1][4].
- Chronic Inflammation and Slow Healers
- Some people just heal slowly—whether due to age, diabetes, or other factors. TB-500 helps regulate the inflammatory response and promotes the cellular processes needed for tissue repair. It essentially tells your body to focus healing resources where they're needed most [1].
Safety profile
Side effects
Relaxin-2 (Serelaxin)
Common
- Hypotension (low blood pressure) - most common
- Tachycardia (increased heart rate)
- Headache
- Nausea
- Dizziness
- Peripheral edema (swelling)
- Increased creatinine levels
- Hyperkalemia (high potassium)
- Syncope (fainting)
- Atrial fibrillation
- Blood pressure checks every 2-4 hours during infusion
- Kidney function (creatinine and eGFR)
- Electrolytes, particularly potassium
- Heart rate and cardiac rhythm
- Urine output
Serious
- Severe cardiovascular events
TB-500
Common
- Injection site redness
- Mild fatigue or lethargy
- Mild headache
- Slight flushing
Uncommon
- Head rush or lightheadedness
- Temporary nausea
Serious
- Allergic reaction
Research status
Safety & evidence
Relaxin-2 (Serelaxin)
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Serelaxin (recombinant relaxin-2) completed Phase III heart failure trials with favorable safety profile and cardiovascular benefit signals. [3][5][9] Hypotension occurs in 20-25% of subjects requiring hemodynamic monitoring; no serious adverse events directly attributable to serelaxin beyond expected vasodilatory effects. [11] Flushing and headaches mild and transient. No serious immunogenicity despite being recombinant human peptide; repeat dosing shows consistent response [12].
Contraindications
- Severe hypotension or hemodynamic instability
- Pregnancy (despite relaxin's natural role)
- Acute kidney injury or severe renal dysfunction
- Recent myocardial infarction (within 7 days)
- Uncontrolled arrhythmias
TB-500
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- TB-500 has shown a good safety profile across preclinical studies and limited human research. It's a fragment of thymosin beta-4, a naturally occurring protein in your body involved in healing. Most side effects are mild and transient, primarily injection site reactions. However, large-scale clinical trials are still needed to fully establish its safety profile in humans [1].
Contraindications
- Pregnancy or planning to become pregnant
- Currently breastfeeding
- Active cancer or history of cancer
- Known allergy to peptide components
- Children and adolescents
Decision guide
Which is right for you?
Relaxin-2 (Serelaxin)
Choose Relaxin-2 (Serelaxin) if…
- Acute heart failure symptom management
- Cardiovascular recovery and support
- Hospital-based therapeutic interventions
TB-500
Choose TB-500 if…
- Accelerating injury recovery
- Tendon and ligament healing
- Reducing chronic inflammation
- Post-surgical recovery support